Independent validation of the concept behind Sprint Biosciences' drug project Vps34
Newly published results from three independent research groups support the concept behind Sprint Biosciences' drug project Vps34. The articles confirm that autophagy in tumors makes it easier for cancer cells to escape attacks from the body's immune system. This external validation leads to an increased interest in the Vps34 project in the pharmaceutical industry and strengthens Sprint Biosciences' position in discussions with potential licensees.Sprint Bioscience were the first to describe how autophagy can promote tumor development in an article published in Science Advances earlier this